1. Home
  2. CNMD vs AMPH Comparison

CNMD vs AMPH Comparison

Compare CNMD & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CONMED Corporation

CNMD

CONMED Corporation

N/A

Current Price

$51.12

Market Cap

985.5M

Sector

Health Care

ML Signal

N/A

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

N/A

Current Price

$28.88

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CNMD
AMPH
Founded
1970
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
985.5M
1.1B
IPO Year
1995
2005

Fundamental Metrics

Financial Performance
Metric
CNMD
AMPH
Price
$51.12
$28.88
Analyst Decision
Hold
Hold
Analyst Count
7
7
Target Price
★ $46.83
$24.50
AVG Volume (30 Days)
387.4K
★ 407.8K
Earning Date
10-28-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 1.87
1.67
Revenue
★ $1,374,724,000.00
$719,887,000.00
Revenue This Year
N/A
$3.81
Revenue Next Year
$4.73
$4.91
P/E Ratio
$27.49
★ $17.44
Revenue Growth
★ 5.18
N/A
52 Week Low
$31.44
$16.65
52 Week High
$54.80
$31.00

Technical Indicators

Market Signals
Indicator
CNMD
AMPH
Relative Strength Index (RSI) 58.28 66.65
Support Level $43.95 $27.24
Resistance Level $53.09 $29.35
Average True Range (ATR) 2.29 1.12
MACD 0.45 0.20
Stochastic Oscillator 66.02 68.18

Price Performance

Historical Comparison
CNMD
AMPH

About CNMD CONMED Corporation

Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: